|
1 Guidelines for Clinical Transfusion Procedures |
|
|
1 | (16) |
|
Clinical Decisions on Transfusion |
|
|
1 | (1) |
|
Assessing the Need for Transfusion |
|
|
1 | (1) |
|
Checklist for Clinicians Prescribing Blood |
|
|
2 | (1) |
|
Requisition for Blood/Blood Components |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
3 | (2) |
|
|
5 | (1) |
|
|
6 | (1) |
|
Protocol for Apheresis Donor |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
Collecting Blood/Products Prior to Transfusion |
|
|
9 | (1) |
|
|
9 | (1) |
|
Dose/Outcome of Blood/Blood Components |
|
|
9 | (1) |
|
Storing Blood Products Prior to Transfusion |
|
|
9 | (2) |
|
Administering Blood Products |
|
|
11 | (2) |
|
|
13 | (1) |
|
Disposable Equipment for Transfusion |
|
|
13 | (1) |
|
|
13 | (1) |
|
Pressure Devices for Rapid Infusion |
|
|
14 | (1) |
|
Recording the Transfusion |
|
|
14 | (1) |
|
Monitoring the Transfused Patients |
|
|
15 | (1) |
|
Acute Transfusion Reactions |
|
|
16 | (1) |
|
Protocol for Adverse Reaction of Blood Transfusion |
|
|
16 | (1) |
|
2 Blood Components and its Uses |
|
|
17 | (12) |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
20 | (2) |
|
|
22 | (2) |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
26 | (3) |
|
|
29 | (13) |
|
|
29 | (1) |
|
|
30 | (2) |
|
|
32 | (2) |
|
|
34 | (4) |
|
|
38 | (1) |
|
Therapeutic Plasmapheresis (Plasma Exchange) |
|
|
39 | (1) |
|
Peripheral Blood Stem Cells |
|
|
39 | (3) |
|
4 Transfusion Practices in Clinical Medicine |
|
|
42 | (20) |
|
|
42 | (1) |
|
Disseminated Intravascular Coagulation |
|
|
43 | (2) |
|
Multi-Transfused Patients |
|
|
45 | (1) |
|
|
46 | (2) |
|
|
48 | (2) |
|
|
50 | (4) |
|
|
54 | (1) |
|
Disorders of Vitamin K-Dependent Coagulation Factors |
|
|
55 | (1) |
|
|
56 | (1) |
|
Autoimmune Hemolytic Anemia |
|
|
56 | (1) |
|
|
57 | (2) |
|
Severe (Decompensated) Anemia |
|
|
59 | (1) |
|
Glucose-6-Phosphate Dehydrogenase Deficiency |
|
|
60 | (1) |
|
|
60 | (1) |
|
Gastrointestinal Bleeding |
|
|
61 | (1) |
|
5 Transfusion Practice in Obstetrics |
|
|
62 | (4) |
|
Blood Loss during Delivery |
|
|
62 | (1) |
|
Transfusion Guidelines for Chronic Anemia in Pregnancy |
|
|
63 | (1) |
|
Major Obstetric Hemorrhage |
|
|
63 | (2) |
|
Disseminated Intravascular Coagulation |
|
|
65 | (1) |
|
Hemolytic Disease of The Newborn |
|
|
65 | (1) |
|
6 Neonatal and Pediatric Transfusion Practice |
|
|
66 | (15) |
|
|
66 | (1) |
|
Hemolytic Disease of Newborn |
|
|
67 | (1) |
|
RhD Hemolytic Disease of Newborn |
|
|
67 | (3) |
|
|
70 | (4) |
|
ABO Hemolytic Disease of the Newborn |
|
|
74 | (1) |
|
Indirect Hyperbilirubinemia |
|
|
75 | (1) |
|
|
76 | (1) |
|
Bleeding and Clotting Disorders in Pediatrics |
|
|
77 | (1) |
|
Acquired Bleeding and Clotting Disorders |
|
|
77 | (1) |
|
|
78 | (1) |
|
|
78 | (1) |
|
Neonatal Alloimmune Thrombocytopenia |
|
|
79 | (1) |
|
Fresh Frozen Plasma in Pediatrics |
|
|
79 | (2) |
|
7 Transfusion Practice in Surgery and Hemorrhage |
|
|
81 | (11) |
|
Red Blood Cell Transfusion in Anemia |
|
|
82 | (1) |
|
|
83 | (1) |
|
Recombinant Activated Factor VII |
|
|
84 | (1) |
|
Surgery and Coagulation Disorders |
|
|
85 | (1) |
|
Anticoagulants: Warfarin, Heparin |
|
|
86 | (1) |
|
Management of a Bleeding Patient who has Received Fibrinolytics or Platelet Inhibitors |
|
|
86 | (4) |
|
Transfusion in Elective Surgery |
|
|
90 | (2) |
|
8 Approach to a Patient of Trauma and Burns |
|
|
92 | (9) |
|
Phase I Assessment and Resuscitation |
|
|
93 | (3) |
|
|
96 | (1) |
|
Phase III Definitive Management |
|
|
96 | (1) |
|
|
96 | (2) |
|
Approach to a Patient of Burns |
|
|
98 | (3) |
|
9 Transfusion in Cardio-Pulmonary Bypass Surgery |
|
|
101 | (4) |
|
|
103 | (2) |
|
10 Transfusion in Transplantation |
|
|
105 | (4) |
|
Transfusion in Bone Marrow Transplantation |
|
|
105 | (2) |
|
Transfusion in Solid Organ Transplantation |
|
|
107 | (2) |
|
11 Transfusion Transmitted Infections |
|
|
109 | (12) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (3) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (2) |
|
|
120 | (1) |
|
12 Transfusion Reactions---Protocol |
|
|
121 | (14) |
|
|
121 | (1) |
|
Acute/Immediate Reactions |
|
|
121 | (1) |
|
Delayed Transfusion Reactions |
|
|
122 | (1) |
|
Management and Investigations |
|
|
123 | (4) |
|
|
127 | (1) |
|
Transfusion Transmitted Infections---Delayed Complications of Transfusion |
|
|
128 | (3) |
|
Errors in Transfusion Process |
|
|
131 | (1) |
|
|
131 | (2) |
|
|
133 | (2) |
|
13 Autologous Transfusion |
|
|
135 | (4) |
|
Types of Autologous Transfusion |
|
|
135 | (4) |
|
|
139 | (2) |
|
|
141 | (3) |
|
|
144 | (5) |
|
17 Hospital Transfusion Committee |
|
|
149 | (3) |
|
18 Plasma Derivatives and Plasma Substitutes |
|
|
152 | (7) |
|
|
|
|
152 | (1) |
|
|
153 | (1) |
|
Factor IX Containing Plasma Derivatives |
|
|
154 | (1) |
|
Immunoglobulin Preparations |
|
|
154 | (1) |
|
|
155 | (4) |
|
19 Alternatives to Transfusion |
|
|
159 | (7) |
|
|
|
|
159 | (1) |
|
Recombinant Hematopoietic Growth Factors |
|
|
160 | (1) |
|
|
161 | (3) |
|
Platelet-Derived Products |
|
|
164 | (2) |
|
20 Recent Advances in Transfusion |
|
|
166 | (4) |
|
|
166 | (1) |
|
|
167 | (1) |
|
Pathogen Inactivation System |
|
|
167 | (1) |
|
|
168 | (1) |
|
Recent Advances in Apheresis |
|
|
168 | (2) |
|
21 Frequently Asked Questions about Transfusion |
|
|
170 | (17) |
|
|
|
|
187 | (6) |
|
|
193 | (22) |
|
|
215 | (16) |
|
|
215 | (2) |
|
|
217 | (1) |
|
III Consent Form for the Transfusion of Blood/Blood Components |
|
|
218 | (2) |
|
|
220 | (2) |
|
V Transfusion Reaction Form |
|
|
222 | (1) |
|
VI Transfusion Reaction Protocol for Clinicians |
|
|
223 | (1) |
|
VII Good Transfusion Practices |
|
|
224 | (1) |
|
VIII Normal Hematological Values in Adults |
|
|
225 | (1) |
|
IX Normal Hematological Values in Children |
|
|
226 | (1) |
|
|
227 | (1) |
|
|
228 | (2) |
|
XII Patients who do not Accept Transfusions |
|
|
230 | (1) |
Suggested Reading |
|
231 | (2) |
Index |
|
233 | |